An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

PiNACLE – H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell ...

AWS is launching Amazon Connect Health, handling patient calls, clinical documentation and billing codes in a new challenge ...

An innovative clinical trial examining whether robotic companion pets can improve the outcomes of hospitalized older adults with dementia has delivered meaningful results that have far-reaching ...

The newly introduced AI-powered study build engine marks the first phase of ClinCapture's broader intelligent trial roadmap. By automating protocol translation, Captivate establishes a foundation for ...

Researchers examined whether an AI-assisted method could improve colon cleansing quality during colonoscopies vs standard care.

Guidelines summarize how persons with a certain disease should be treated according to current knowledge, thereby supporting ...

Myomo, Inc. ( MYO) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT Good day, and welcome to the Myomo Fourth Quarter and Full Year 2025 Financial Results. [Operator Instructions] Please note, this ...

Introduction Lower extremity Ilizarov surgery, a common procedure for correcting bone deformities, is often associated with reduced physical activity (PA) and functional decline. The home-based PA ...

Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reac | Three ...